2025-04-23 - Analysis Report
## TEM: Unknown Company Stock Report

**Summary Statistics:**

* **Ticker:** TEM
* **Company:** Unknown Company (requires further research for a concise overview)
* **Cumulative Return (TEM):** 5.35%
* **Cumulative Return (VOO):** -7.22%
* **Return Difference (TEM vs VOO):** 12.57% (TEM outperformed VOO by 12.57% at the end of the period)
* **Relative Divergence:** 27.2% (TEM's performance is in the 27.2nd percentile relative to its historical performance vs. VOO, considering the range from -22.6% to 107%)
* **Current Price:** $43.23


**1. Performance Comparison & Alpha/Beta Analysis:**

TEM significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return difference of 12.57% highlights this outperformance. However, the provided alpha of -0.1 suggests that, adjusted for market risk (beta of 7.3), TEM underperformed its benchmark. The high beta (7.3) indicates significantly higher volatility than the market.  Further investigation is needed to understand the drivers of this outperformance despite a negative alpha. The high market risk and negative alpha need further analysis.  A CAGR of 5.0% over 2023-2025 is modest considering the high risk.


**2. Recent Price Movements:**

* **Closing Price:** $43.23
* **5-Day Moving Average:** $41.69
* **20-Day Moving Average:** $45.17
* **60-Day Moving Average:** $54.70

The price is currently below all three moving averages, suggesting a potential short-term downtrend.  The recent price increase of 5.49% (from $40.98) indicates a potential short-term rebound, but the trend is bearish.

**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.435 (Medium Risk)
* **RSI:** 44.12 (Slightly below neutral; not oversold)
* **PPO:** 0.21 (Positive, suggesting potential upward momentum)
* **20-Day Relative Divergence Change:** +1.2 (Short-term upward trend)
* **Expected Return:** nan (unavailable)


The technical indicators present a mixed signal.  While the PPO is positive, the RSI is close to the neutral zone and the price is below its moving averages. The recent price increase is significant (5.49%) and may suggest a short-term rebound.  The lack of an expected return value requires further analysis and prediction modelling.

**4. Recent Earnings Analysis:**

| Date       | EPS     | Expected EPS | Difference |
|------------|---------|--------------|------------|
| 2025-02-24 | -0.18   | -0.15        | -0.03       |
| 2024-11-04 | -0.25   | -0.26608     | +0.016     |
| 2024-08-06 | -0.63   | -0.59        | -0.04       |

The company has reported negative EPS in recent quarters. While there were some positive surprises (November 2024), overall, the company is consistently underperforming its earnings expectations, suggesting challenges in profitability.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin | Revenue Growth (YoY) |
|------------|-------------|---------------|-----------------------|
| 2024-12-31 | $0.20B      | 60.83%        | 33.33%                 |
| 2024-09-30 | $0.18B      | 58.50%        | 20.00%                 |
| 2024-06-30 | $0.17B      | 45.50%        | 13.33%                 |
| 2024-03-31 | $0.15B      | 53.28%        | 0%                    |
| 2023-12-31 | $0.15B      | 55.20%        | -                |

**Capital and Profitability:**

| Quarter    | Equity      | ROE           |
|------------|-------------|---------------|
| 2024-12-31 | $0.06B      | -23.10%       |
| 2024-09-30 | $0.05B      | -141.16%      |
| 2024-06-30 | $0.10B      | -562.04%      |
| 2024-03-31 | $-1.47B     | 4.39%         |
| 2023-12-31 | $-1.38B     | 3.65%         |

Revenue shows consistent growth, but profit margins fluctuate and have decreased in Q2 2024.  Extremely negative ROE values in several quarters are alarming and require urgent investigation into the company's financial health.  The large negative equity raises serious concerns.

**6. Overall Analysis:**

TEM shows significant outperformance compared to the S&P 500 in terms of cumulative returns. However, this is accompanied by high volatility (high beta), negative alpha, and concerning financial indicators.  The negative EPS, fluctuating profit margins, and drastically negative ROE figures raise significant red flags about the company's long-term sustainability and profitability.  While the recent price increase might be interpreted as a short-term rebound, the underlying financial health of the company needs thorough investigation before any investment decision can be made. The high risk associated with this stock, as evidenced by the high beta, negative alpha, and volatile financials, should be carefully considered.  Further research into the "Unknown Company" is crucial to gain a better understanding of its business model and future prospects.  The data presented suggests caution and warrants in-depth due diligence before considering an investment in TEM.
